Quercetin, a flavonoid present in many fruits and vegetables, exhibits beneficial effects toward abnormalities related to metabolic syndrome. In this study, to further investigate metabolic and transcriptomic responses to quercetin supplementation, we used a genetic model of metabolic syndrome. Adult male rats of the PD/Cub strain were fed either a high-sucrose diet (HSD; control PD rats) or HSD fortified with quercetin (10 g quercetin/kg diet; PD-Q rats). Morphometric and metabolic parameters, along with transcriptomic profiles of the liver and retroperitoneal fat, were assessed. The relative weights of epididymal and retroperitoneal fat were significantly decreased in quercetin-treated animals. Furthermore, a smaller area under the glycemic curve along with a decreased level of fasting insulin were detected in PD-Q rats. While no changes in total cholesterol levels were observed, the overall level of triglycerides decreased in the serum and the liver of the PD-Q rats. The transcriptomic profile of the liver and the adipose tissue corroborated the metabolic and morphometric findings, revealing the pattern consistent with insulin-sensitizing changes, with major regulator nodes being Pparg, Adipoq, Nos2, and Mir378. In conclusion, quercetin supplementation improves abnormalities related to metabolic syndrome, namely adiposity, dyslipidemia and glucose intolerance.

1st Faculty of Medicine Institute of Biology and Medical Genetics General University Hospital Charles University Prague Czechia

Center for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czechia

Zobrazit více v PubMed

Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. PubMed DOI PMC

Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. PubMed DOI

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. PubMed DOI PMC

Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. PubMed DOI PMC

Grundy SM. Adipose tissue and metabolic syndrome: too much, too little or neither. PubMed DOI PMC

McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. PubMed DOI

Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. PubMed DOI PMC

Scholze J, Alegria E, Ferri C, Langham S, Stevens W, Jeffries D, et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. PubMed DOI PMC

Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the united states, 2011-2016. PubMed DOI PMC

Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. PubMed DOI PMC

Lillich FF, Imig JD, Proschak E. Multi-target approaches in metabolic syndrome. PubMed DOI PMC

Anand David AV, Arulmoli R, Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. PubMed DOI PMC

Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. PubMed DOI

Chen S, Jiang H, Wu X, Fang J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. PubMed DOI PMC

Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. Therapeutic potential of quercetin as a cardiovascular agent. PubMed DOI

Panchal SK, Poudyal H, Brown L. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. PubMed DOI

Hosseini A, Razavi BM, Banach M, Hosseinzadeh H. Quercetin and metabolic syndrome: a review. PubMed DOI

Yi H, Peng H, Wu X, Xu X, Kuang T, Zhang J, et al. The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence. PubMed DOI PMC

Bendlova B, Vankova M, Hill M, Vacinova G, Lukasova P, Vejrazkova D, et al. ZBTB16 gene variability influences obesity-related parameters and serum lipid levels in Czechia adults. PubMed DOI

Šeda O, Šedová L, Vèelák J, Vaòková M, Liška F, Bendlová B. ZBTB16 and metabolic syndrome: a network perspective. PubMed DOI

Bíla V, Kren V, Liska F. The influence of the genetic background on the interaction of retinoic acid with Lx mutation of the rat. PubMed

Liska F, Snajdr P, Sedova L, Seda O, Chylikova B, Slamova P, et al. Deletion of a conserved noncoding sequence in Plzf intron leads to Plzf down-regulation in limb bud and polydactyly in the rat. PubMed DOI

Sedová L, Kazdová L, Seda O, Krenová D, Kren V. Rat inbred PD/cub strain as a model of dyslipidemia and insulin resistance. PubMed

Krupkova M, Liska F, Kazdova L, Sedova L, Kabelova A, Krenova D, et al. Single-gene congenic strain reveals the effect of Zbtb16 on dexamethasone-induced insulin resistance. PubMed DOI PMC

Sedová L, Seda O, Kazdová L, Chylíková B, Hamet P, Tremblay J, et al. Sucrose feeding during pregnancy and lactation elicits distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. PubMed DOI

Cahova M, Dankova H, Palenickova E, Papackova Z, Kazdova L. The opposite effects of high-sucrose and high-fat diet on fatty acid oxidation and very low density lipoprotein secretion in rat model of metabolic syndrome. PubMed DOI PMC

de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, et al. Tissue distribution of quercetin in rats and pigs. PubMed DOI

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. PubMed DOI

Després J-P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. DOI

Moon J, Do H-J, Kim OY, Shin M-J. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. PubMed DOI

Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P, et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. PubMed DOI

Nabavi SF, Russo GL, Daglia M, Nabavi SM. Role of quercetin as an alternative for obesity treatment: you are what you eat! PubMed DOI

Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. PubMed DOI

Patel P, Abate N. Body fat distribution and insulin resistance. PubMed DOI PMC

Bule M, Abdurahman A, Nikfar S, Abdollahi M, Amini M. Antidiabetic effect of quercetin: a systematic review and meta-analysis of animal studies. PubMed DOI

Shi G-J, Li Y, Cao Q-H, Wu H-X, Tang X-Y, Gao X-H, et al. PubMed DOI

Gomes I, Porto M, Santos MC, Campagnaro B, Gava A, Meyrelles S, et al. The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice. PubMed DOI PMC

Xie J, Song W, Liang X, Zhang Q, Shi Y, Liu W, et al. Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level. PubMed DOI

Chai GR, Liu S, Yang HW, Chen XL. Quercetin protects against diabetic retinopathy in rats by inducing heme oxygenase-1 expression. PubMed DOI PMC

Eid HM, Haddad PS. The antidiabetic potential of quercetin: underlying mechanisms. PubMed DOI

Li J-M, Wang W, Fan C-Y, Wang M-X, Zhang X, Hu Q-H, et al. Quercetin preserves β-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. PubMed DOI PMC

Ghorbani A, Rashidi R, Shafiee-Nick R. Flavonoids for preserving pancreatic beta cell survival and function: a mechanistic review. PubMed DOI

Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. PubMed DOI PMC

Nilsson PM, Tuomilehto J, Rydén L. The metabolic syndrome – What is it and how should it be managed? PubMed DOI

Guo W, Gong X, Li M. Quercetin actions on lipid profiles in overweight and obese individuals: a systematic review and meta-analysis. PubMed DOI

Huang H, Liao D, Dong Y, Pu R. Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. PubMed DOI

Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. PubMed DOI

Kuipers EN, Dam ADV, Held NM, Mol IM, Houtkooper RH, Rensen PCN, et al. Quercetin lowers plasma triglycerides accompanied by white adipose tissue browning in diet-induced obese mice. PubMed DOI PMC

Wang M, Wang B, Wang S, Lu H, Wu H, Ding M, et al. Effect of quercetin on lipids metabolism through modulating the gut microbial and AMPK/PPAR signaling pathway in broilers. PubMed DOI PMC

Wang Q, Sharma VP, Shen H, Xiao Y, Zhu Q, Xiong X, et al. The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation. PubMed DOI PMC

Norheim F, Hui ST, Kulahcioglu E, Mehrabian M, Cantor RM, Pan C, et al. Genetic and hormonal control of hepatic steatosis in female and male mice. PubMed DOI PMC

Li J, Bardag-Gorce F, Oliva J, Dedes J, French BA, French SW. Gene expression modifications in the liver caused by binge drinking and S-adenosylmethionine feeding. The role of epigenetic changes. PubMed DOI PMC

Covill-Cooke C, Toncheva VS, Drew J, Birsa N, Lopez-Domenech G, Kittler JT. Peroxisomal fission is modulated by the mitochondrial Rho-GTPases. Miro1 and Miro2. PubMed DOI PMC

Ruskovska T, Budiæ-Leto I, Corral-Jara KF, Ajdžanoviæ V, Arola-Arnal A, Bravo FI, et al. Systematic analysis of nutrigenomic effects of polyphenols related to cardiometabolic health in humans - Evidence from untargeted mRNA and miRNA studies. PubMed DOI

Yuan K, Ai WB, Wan LY, Tan X, Wu JF. The miR-290-295 cluster as multi-faceted players in mouse embryonic stem cells. PubMed DOI PMC

Carrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, et al. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. PubMed DOI PMC

Seda O, Sedova L. Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and type 2 diabetes. PubMed DOI

Scheja L, Heeren J. The endocrine function of adipose tissues in health and cardiometabolic disease. PubMed DOI

Coppi L, Ligorio S, Mitro N, Caruso D, De Fabiani E, Crestani M. PGC1s and beyond: disentangling the complex regulation of mitochondrial and cellular metabolism. PubMed DOI PMC

McDowell SAC, Luo RBE, Arabzadeh A, Dore S, Bennett NC, Breton V, et al. Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration. PubMed DOI

Šeda O, Tremblay J, Gaudet D, Brunelle P-L, Gurau A, Merlo E, et al. Systematic, genome-wide, sex-specific linkage of cardiovascular traits in french canadians. PubMed DOI

Quercetin supplementation in metabolic syndrome: nutrigenetic interactions with the Zbtb16 gene variant in rodent models